AI Visibility Scorecard
AMONDYS 45 (casimersen)
skipexon45.com · Healthcare
Borderline visible. AI bots can crawl AMONDYS 45 (casimersen), but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 5 times
Apple Intelligence · Meta AI · Claude
#473,983 of 923,184 in Healthcare for AI visibility
5
AEO Visibility
iBorderline · 4.7/10
0
Muse Index Score
iAI agent readiness
Basic · 0/100
0
AI Adoption
iNone detected · 0/100
About AMONDYS 45 (casimersen)
from skipexon45.com
AMONDYS 45 (casimersen) is an FDA-approved product. Learn more.
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Strong
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.7/10, AMONDYS 45 (casimersen) is crawlable but under-signaled - fixable, and the signals above are where to start.
Frequently Asked Questions
Who Can Take It?
Learn the importance of understanding your genetic mutation and what it means to be amenable to treatment with AMONDYS 45.Learn About Amenability
What is AMONDYS 45 (casimersen)?
AMONDYS 45 is used to treat patients with Duchenne muscular dystrophy (DMD) who have a confirmed mutation of the dystrophin gene that can be treated by skipping exon 45.This indication is approved under accelerated approval based on an increase in dystrophin production in skeletal muscle observed in patients treated with AMONDYS 45.
Is this your brand?
The exact fixes for AMONDYS 45 (casimersen)
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for AMONDYS 45 (casimersen).
Source & Attribution
Scored by Engagemii on August 2, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/skipexon45
Cite this score: Engagemii (2026). "AEO Score for AMONDYS 45 (casimersen)." Retrieved from https://engagemii.com/aeo/brands/skipexon45
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform